Structured monitoring: The right tools for the job

Structured monitoring - or self-monitoring of blood glucose (SMBG) with a plan and a purpose - can take different forms and can be extremely useful in influencing patient behaviour. It not only gives your patients periodic updates on their blood glucose levels, but also provides data that can inform conversations to maximise therapy outcomes.

Checking blood sugar levels with Accu-Chek Instant meter

National and international diabetes organisations view structured SMBG as a valuable supplementary tool for recording the acute and intra-day details behind three-month HbA1c measurements. However, healthcare professional-to-patient communication and a clear understanding of the goal and therapeutic element being addressed is a vital component of success.

According to the International Diabetes Federation’s Guideline for Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes, communication and intent are key to structured monitoring1:

  • SMBG should be used when patients and healthcare professionals have the knowledge, skills and willingness to incorporate SMBG monitoring and therapy adjustment
  • SMBG protocols (intensity and frequency) should be individualised to address each patient’s educational, behavioural and clinical needs.

Why use structured monitoring?

Focused monitoring—intensive monitoring for a limited duration to address a specific issue
Focused monitoring—intensive monitoring for a limited duration to address a specific issue
SMBG examples Purpose Action
Pattern testing <ul><li>Issue identification</li><li>Education or awareness</li><li>Engagement; unbiased motivator for diabetes self-management</li></ul> <ul><li>Therapy adjustment</li><li>Behaviour change</li></ul>
Paired testing <ul><li>Education or awareness</li><li>Engagement; self-management</li><li>Bolus calculation</li><li>Bolus type/frequency in pump therapy</li></ul> <ul><li>Therapy adjustment</li><li>Behaviour change</li></ul>
Titration testing <ul><li>Insulin regime: total daily dose (TDD), bolus/basal doses</li><li>Bolus type/frequency in pump therapy</li></ul> <ul><li>Therapy adjustment</li></ul>
Individualised monitoring over longer periods of time
Individualised monitoring over longer periods of time
SMBG examples Purpose Action
Insulin management testing Insulin regime: TDD, bolus/basal doses Adjust dosage, timing, or insulin type
Lifestyle intervention testing Glycaemic management in non-insulin requiring people with diabetes Behaviour change: activity, stress, schedule, diet, snacking, alcohol

Structured monitoring examples

Examples
Monitoring regime Description Application
Staggered profile Pre- and postprandial BG measurements for one meal per day or overnight Staggering mealtimes provides more data and a clearer picture of glucose levels and patterns
7-point profile Pre- and postprandial BG measurements for three meals per day and bedtime BG for a short time period, such as three consecutive days For an overall assessment of the glucose profile, such as before a clinical visit
Paired testing Pre- and postprandial BG measurements for the same meal (breakfast, lunch, or dinner) on seven consecutive days Specific mealtime data for evaluation of postprandial glucose excursions; can support identification of the need for additional medications or therapy changes to target postprandial hyperglycaemia
  1. International Diabetes Federation Clinical Guidelines Task Force, SMBG International Working Group. Guideline on Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes. 2009. https://d-net.idf.org/en/library/190-self-monitoring-of-blood-glucose-i…

Additional sources:

Di Molfetta S, Bosi E, Ceriello A, Cucinotta D, Tiengo A, Scavini M, Piccolo C, Bonizzoni E, Acmet E, Giorgino F; PRISMA STUDY GROUP. Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: a novel analysis of data from PRISMA. Diabetes Res Clin Pract. 2021 Sep 27;109070. doi: 10.1016/j.diabres.2021.109070

Russo GT, Scavini M, Acmet E, Bonizzoni E, Bosi E, Giorgino F, Tiengo A, Cucinotta D. The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study. Diabetes Technol Ther. 2016 Jul;18(7):421-8. doi:10.1089/dia.2015.0358. Epub 2016 Jun 21.

Scavini M, Bosi E, Ceriello A, Giorgino F, Porta M, Tiengo A, Vespasiani G, Bottalico D, Marino R, Parkin C, Bonizzoni E, Cucinotta D. Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention. Acta Diabetol. 2013 Oct;50(5):663-72. doi: 10.1007/s00592-011-0357-y.

 

Connect with an Accu-Chek representative

Do you have questions, or are you ready to see a demo? <br>Schedule a call, and we'll show you what we can do for you, your team, and your patients.

Request demo